Table 2 Description of repeated uric acid measures and outcomes over the follow-up in the population included in our analysis (N = 2781).
Median (IQR 25–75) | n (%) | |
|---|---|---|
Total number of UA measures over follow-up | 16,947 | |
Number of UA measures by patient | 5 (3–8) | |
Time interval between two consecutive UA measures (days) | 120 (63—197) | |
Number of patients with | ||
Only one UA measure | 231 (8.3) | |
Two UA measures | 272 (9.8) | |
Three UA measures | 323 (11.6) | |
More than three UA measures | 1955 (70.5) | |
Number of UA measures over follow-up in each of the following UA value classes | ||
< 4 mg/dl | 808 (4.8) | |
4–6 mg/dl | 4203 (24.8) | |
6–8 mg/dl | 6509 (38.4) | |
8–10 mg/dl | 4022 (23.7) | |
> 10 mg/dl | 1405 (8.3) | |
Number of patients with | ||
Kidney failure | 439 (15.8%) | |
Death before kidney failure | 264 (9.5%) | |
